Keywords: CECs; Cerebral Endothelial Cells; HE; Hepatic Encephalopathy; IL; Interleukin; LPS; Lipopolysaccharide; MPA; Monocyte Platelet Aggregate; PSGL-1; Anti-P-Selectin Glycoprotein 1; QoL; Quality of Life; SIBO; Small Intestinal Bacterial Overgrowth; TNF-α; Tu
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AKI; acute kidney injury; BMD; bone mineral density; CAP; community-acquired pneumonia; CDI; Clostridium difficile infection; CKD; chronic kidney disease; FDA; Food and Drug Administration; NSAID; nonsteroidal anti-inflammatory drug; OR; odds ratio; PPI;
Keywords: cardiovascular; comorbidity; environment; gastrointestinal; genetics; immune; microbiome; neurologic; pathophysiology; rosacea; CeD; celiac disease; CVD; cardiovascular disease; GST; glutathione-S-transferase; GWAS; genome-wide association study; HLA; hum
Keywords: IBS; irritable bowel syndrome; SIBO; small intestine bacterial overgrowth;
Keywords: Bacterial overgrowth; SIBO; Dybiosis; Intestinal inflammation; Dysmotility; CF intestine; Probiotics;
Keywords: Diarrhea; Definitions; Classification; Diet; Diagnostic Testing; Therapy; BAM; bile acid malabsorption; CD; celiac disease; CT; computed tomography; EGD; esophagogastroduodenoscopy; GI; gastrointestinal; HIV; human immunodeficiency virus; IBD; inflammator
Keywords: Acid Suppression; Cognitive Dysfunction; Gut Microbiota; Liver Failure; cDDD; cumulative defined daily dose; CI; confidence interval; DDD; defined daily dose; GI; gastrointestinal; HE; hepatic encephalopathy; ICD-9-CM; International Classification of Dise
Keywords: Diarrhea; Pathophysiology; Management; ATPase; adenosine triphosphatase; cAMP; cyclic adenosine monophosphate; Cg; chromogranin; cGMP; cyclic guanosine monophosphate; ENaC; epithelial sodium channel; 5-HT; 5-hydroxytryptamine; FODMAP; fermentable oligosac
Keywords: GI; gastrointestinal; IBS; irritable bowel syndrome; SIBO; small intestinal bacterial overgrowth;
Keywords: ADR; adenoma detection rate; BMI; body mass index; CRC; colorectal cancer; DM; diabetes mellitus; HE; hepatic encephalopathy; MELD; Model for End-Stage Liver Disease; SBP; spontaneous bacterial peritonitis; SIBO; small intestinal bacterial overgrowth; bow
Keywords: Value of Healthcare; Lowering Costs of Healthcare; CD; celiac disease; CLP; cystic lesions of the pancreas; CT; computerized tomography; EUS; endoscopic ultrasound; IBD; inflammatory bowel disease; IBS; irritable bowel syndrome; MRCP; magnetic resonance c
Keywords: EGD; esophagogastroduodenoscopy; GI; gastrointestinal; GOO; gastric outlet obstruction; GRSs; gas-related symptoms; IBS; irritable bowel syndrome; IBS-D; irritable bowel syndrome-diarrhea; SBO; small bowel obstruction; SIBO; small intestine bacterial ov
Keywords: ALT; alanine aminotransferase; BMP; bone morphogenetic protein; BT; bacterial translocation; CFU; colony-forming unit; DAMP; damage associated molecular patterns; FIAF; fasting-induced adipose factor; HSCs; hepatic stellate cells; IM; intestinal microbiot
Keywords: CD; celiac disease; NAFLD; non-alcoholic fatty liver disease; NASH; non-alcoholic steatohepatitis; SIBO; small intestinal bacterial overgrowth; VA; villous atrophy; ICD; international classification of disease (codes); CI; confidence Interval; HR; hazard
Keywords: NACSELD; Decompensation; Antibiotic; Complication; CARS; compensatory anti-inflammatory response system; CI; confidence interval; CTP; Child-Turcotte-Pugh; DRO; drug-resistant organism; MELD; model for end-stage liver disease; NACSELD; North American
Keywords: ACLF; acute-on-chronic liver failure; ALF; acute liver failure; HE; hepatic encephalopathy; GLS; glutaminase; ROS; reactive oxygen species; IL; interleukin; TNF; tumour necrosis factor; BT; bacterial translocation; SIBO; small intestinal bacterial overgro
Keywords: ALT; alanine aminotransferase; AMPK; AMP-activated protein kinase; AST; aspartate aminotransferase; CDAA diet; choline-deficient/l-amino acid-defined diet; GLP-2; glucagon-like peptide-2; HFD; high fat diet; IL-1; interleukin 1; IL-6; interleukin 6; Fiaf;
Keywords: ASA; acetylsalicylic acid; CE; capsule endoscopy; GI; gastrointestinal; IBD; inflammatory bowel disease; IBS; irritable bowel syndrome; NAFLD; nonalcoholic fatty liver disease; NSAID; nonsteroidal anti-inflammatory drug; PPI; proton pump inhibitor; SIBO;
Keywords: AMP; antimicrobial peptides; APC; antigen-presenting cell; BDL; bile duct ligation; BT; bacterial translocation; CCl4; carbon-tetrachloride; DC; dendritic cell; FxR; Farnesoid X receptor; GALT; gut-associated lymphoid tissue; GI; gastrointestinal; GNB; gr
Small intestinal bacterial overgrowth in Parkinson's disease: Tribulations of a trial
Keywords: Parkinson disease; SIBO; Motor fluctuations; Clinical trial; Small intestinal bacterial overgrowth;
Functional 13C-urea and glucose hydrogen/methane breath tests reveal significant association of small intestinal bacterial overgrowth in individuals with active Helicobacter pylori infection
Keywords: 13C-UBT; 13C-urea breath test; SIBO; small intestinal bacterial overgrowth; H2; hydrogen; CH4; methane; HMBT; hydrogen methane breath test; PPI; proton pump inhibitor; δ; delta; κ; kappa; CI; confidence interval; Functional breath testing; Helicobacter
Research ArticleProton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: A multicenter prospective study
Keywords: PPI; proton pump inhibitor; SBP; spontaneal bacterial peritonitis; HBV; hepatitis B virus; SIBO; small intestinal bacterial overgrowth; GHBT; glucose hydrogen breath testing; Proton pump inhibitor; Spontaneous bacterial peritonitis; Cirrhosis;
Current views on the etiopathogenesis, clinical manifestation, diagnostics, treatment and correlation with other nosological entities of SIBO
Keywords: SIBO; Management; Diagnostics; Treatment;
Reported Side Effects and Complications of Long-term Proton Pump Inhibitor Use: Dissecting the Evidence
Keywords: BMD; bone mineral density; CAP; community-acquired pneumonia; CI; confidence interval; FDA; Food and Drug Administration; GI; gastrointestinal; H2RA; histamine 2-receptor antagonist; IBS; irritable bowel syndrome; OR; odds ratio; PPI; proton pump inhibi
Proton Pump Inhibitor Use and the Risk of Small Intestinal Bacterial Overgrowth: A Meta-analysis
Keywords: Hypochlorhydria; Drug; Small Bowel Flora; Reflux; Side Effect; CI; confidence interval; GHBT; glucose hydrogen breath test; OR; odds ratio; PPI; proton pump inhibitor; SIBO; small intestinal bacterial overgrowth;
Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth
Keywords: Restless legs syndrome (RLS); Irritable bowel syndrome (IBS); Small intestinal bacterial overgrowth; SIBO; Lactulose breath test (LBT); Prevalence
Bacterial Overgrowth and Methane Production in Children with Encopresis
Keywords: FI; Fecal impaction; LBT; Lactulose breath test; SIBO; Small intestinal bacterial overgrowth;
Small Intestinal Bacterial Overgrowth in Rosacea: Clinical Effectiveness of Its Eradication
Keywords: BT; breath test; GA; global assessment; G-BT; glucose breath test; GSS; global symptomatic score; Hp; Helicobacter pylori; LH-BT; lactulose breath test; NASH; nonalcoholic steatohepatitis; OCTT; orocecal transit time; SIBO; small intestinal bacterial over
A 51-Year-Old With Irritable Bowel Syndrome: Test or Treat for Bacterial Overgrowth?
Keywords: IBS; irritable bowel syndrome; SIBO; small intestinal bacterial overgrowth;
Enteric Microbial Flora, Bacterial Overgrowth, and Short-Bowel Syndrome
Keywords: SBS; short-bowel syndrome; SIBO; small intestinal bacterial overgrowth;